Blind Wine Tasting is Fun! But you wouldn't go blind into Wine Investing without consulting Wine Experts...would you?
From time to time we get irate investors ranting on about some of their wines. What happens in the world of private investment is that people buy certain wines either because it seemed like a good idea at the time or because they were the victim of a potent sales pitch. When these punts, for that is essentially what they are, go wrong it is usually the fault of the market.
Here’s one for you. If Fine Wine is the investment opportunity it is touted to be, with the mass of graphs and charts that support its record of strong returns over a long enough time period to demonstrate consistency...
How come it is not a default asset choice for just about every investor maintaining a portfolio with an eye on growth?
Fine wine is now the best-performing collectible of the world's wealthy collectors, with values soaring 25 percent over the past 12 months, according to a new report.
The Knight Frank Luxury Investment Index, which tracks the price growth in the major categories of collectibles, found that wine has replaced classic cars as the top collectible. Thanks to strength in Bordeaux, Burgundy and northern Italian wines, collectible wine prices surged 25 percent over the past year and are up 61 percent over the past five years.
Probably the world’s most successful modern airline brand, Dubai-based Emirates, has announced this week that it has invested over US$500 million in fine wine over the last decade.
Following an investment strategy which includes en primeur purchases, Emirates claims to hold 1.2million bottles in their own cellars in Burgundy where they are held for at least a decade before being poured to First and Business class travellers as they traverse the globe.
Other than being purveyors of fine wine, it's also really important to us that we do what we can for local charities. One such charity is the Royal Marsden Cancer Charity who have helped to raise over £8.2 million in the fight against cancer through their 'Marsden March'.